| Literature DB >> 31750973 |
Valentina Straniero1, Victor Sebastián-Pérez2, Martina Hrast3, Carlo Zanotto4, Andrea Casiraghi1, Lorenzo Suigo1, Irena Zdovc5, Antonia Radaelli4, Carlo De Giuli Morghen6, Ermanno Valoti1.
Abstract
FtsZ is a crucial prokaryotic protein involved in bacterial cell replication. It recently arose as a promising target in the search for antimicrobial agents able to fight antimicrobial resistance. In this work, going on with our structure-activity relationship (SAR) study, we developed variously 7-substituted 1,4-benzodioxane compounds, linked to the 2,6-difluorobenzamide by a methylenoxy bridge. Compounds exhibit promising antibacterial activities not only against multidrug-resistant Staphylococcus aureus, but also on mutated Escherichia coli strains, thus enlarging their spectrum of action toward Gram-negative bacteria as well. Computational studies elucidated, through a validated FtsZ binding protocol, the structural features of new promising derivatives as FtsZ inhibitors.Entities:
Keywords: 1,4-benzodioxane-2,6-difluorobenzamide; FtsZ inhibition; Mutated E. coli; cavity detection; molecular modelling
Mesh:
Substances:
Year: 2019 PMID: 31750973 DOI: 10.1002/cmdc.201900537
Source DB: PubMed Journal: ChemMedChem ISSN: 1860-7179 Impact factor: 3.466